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ABSTRACT
Objectives: Smokers report that smoking is
therapeutic; a recent meta-analysis suggests the
contrary. However, the association in that review may
be explained by group-membership bias and
confounding. Propensity score matching (PSM) aims
to produce causal estimates from observational data.
We examined the association between cessation and
change in mental health before and after PSM.
Design: A secondary analysis of prospective data from
5 placebo-controlled randomised trials for smoking
reduction.
Participants: All participants were adult smokers and
had smoked for at least 3 years. Participants were
excluded if they were pregnant, breast feeding, under
psychiatric care, deemed to be unfit by a general
practitioner or part of a cessation programme. In total,
937 participants provided smoking data at both 6-
month and 12-month follow-ups. Of these, 68 were
confirmed as abstinent at both 6 and 12 months and
589 as continuous smokers at both follow-ups.
Primary outcome: Change in mental health (36-item
Short Form Survey (SF-36), scored 0–100) from
baseline (while all participants were smokers) to 12-
month follow-up (after cessation) was compared
between quitters and continuing smokers with and
without adjustment, and after PSM.
Results: Before matching, quitters’ mental health
scores improved compared with continuing smokers’,
the mean difference and 95% CI was 5.5 (1.6 to 9.4).
After adjustment, the difference was 4.5 (0.6 to 8.5),
and after PSM, the difference was 3.4 (−2.2 to 8.9).
Conclusions: Improvements in mental health after
smoking cessation may be partly but not completely
explained by group membership bias and confounding.
BACKGROUND
Most smokers want to quit1 2 but report con-
tinuing to smoke because they feel that
smoking helps them cope with stress and
offers other mental health beneﬁts.3–9 Our
recent systematic review found strong and
consistent evidence that the opposite was
true.10 Smokers who quit showed marked
improvements in mental health over time,
while smokers who continued smoking
showed little change during the same period.
We concluded that the strongest explanation
for this ﬁnding was that cessation caused the
improvement in mental health. However,
critics countered that membership bias or
confounding were possible explanations of
the ﬁndings.11 Very few studies in our review
made any attempt to control confounding
and none addressed membership bias.
As it is not feasible to assign participants
randomly to continue smoking or to quit
smoking, observational studies are the only
source of data to assess the association
between smoking and quitting on mental
health. Regression modelling is commonly
used to account for confounding by adjusting
the association of interest for the effect of
other variables associated with the outcome
and the exposure variable. However, adjust-
ment may not adequately account for mem-
bership bias arising from characteristics
which differ by smoking status. An alternative
method that may account for membership
bias as well as confounding is propensity
score matching (PSM). PSM involves match-
ing individuals within a sample based on
Strengths and limitations of this study
▪ The largest study to date examining the associ-
ation between smoking cessation and change in
mental health using propensity score matching.
▪ Use of a psychometrically sound mental health
measure, which is sensitive to change.
▪ Use of propensity score matching to reduce con-
founding and bias from group membership.
▪ Presents a low risk of bias according to the
Newcastle-Ottawa Scale for Quality Assessment
of Observational Studies.
▪ Attrition was high, although the rate was similar
to other studies of smoking interventions.
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their propensity to belong to an exposure group, or
here, matching on the propensity to quit or continue
smoking without considering the association of those
variables with the outcome.12 13 Thus, by balancing cov-
ariate distribution between groups, confounding by
those variables is eliminated. In addition, PSM can
account for some unmeasured factors if they are corre-
lated with observed covariates. Therefore, some unmeas-
ured confounding associated with propensity to quit
smoking may also be equalised by this process13 further
reducing bias and providing a more accurate estimate of
the association between cessation and change in mental
health.12 13
One disadvantage of PSM is that it often reduces the
size of the sample available to estimate the strength of
the association between cessation and mental health
because it requires participants to be matched. If the
association between stopping smoking and mental
health is inﬂuenced by membership bias or other con-
founding, effect estimates derived from a sample of par-
ticipants matched on their propensity to quit may show
a weaker association. The aim of this study was to esti-
mate the strength of the association between cessation
and change in mental health using a regression model
adjusting for covariates, and compare this with the esti-
mate derived from PSM.
METHODS
This study followed STROBE reporting guidelines for
observational studies.14 PSM procedures were conducted
and reported following criteria outlined by Thoemmes
and Kim.15
Study design and setting
This was a secondary analysis of prospective individual-
level patient data from ﬁve merged placebo-controlled
randomised trials of nicotine replacement therapy
(NRT) for smoking reduction; these data were provided
by McNeil pharmaceutical company (see reports of trials
for further details: K Haustein. A double-blind, rando-
mized, placebo-controlled multicentre trial of a nicotine
chewing gum in smoking reduction. Study ID
980-CHC-9021-0013. Unpublished, 2001 and refs.16–19).
Attrition rates in these trials were similar to other trials
of NRT.20
Study size
The trials took place between 1997 and 2003. In total,
937 participants provided data at both 6-month and
12-month follow-ups. Of these, 68 were conﬁrmed as
abstinent at both 6 and 12 months and 589 as continu-
ous smokers at both follow-ups. Participants who did not
meet exposure criteria were excluded from the analysis.
Participants
All participants were adult smokers of least 3 years and
were selected because they wanted to reduce but not
stop smoking. Participants were excluded if they were
pregnant or breast feeding, under psychiatric care,
deemed to be unﬁt by a general practitioner, or part of
a cessation programme.
At baseline, investigators gathered data on partici-
pants’ demographic details and age started smoking,
cigarettes per day (CPD), nicotine dependence
(Fagerström Test of Nicotine Dependency (FTND)),21
intention to quit, intention to reduce, smoking history
(eg, number of previous quit attempts, longest period
without smoking), self-rated effects from smoking
(‘Relief from smoking questionnaire’ K Haustein,
unpublished data, 2001), mental health (36-item Short
Form Survey, SF-36)22 23 (see online supplementary
table S1). To preserve participant anonymity, some
demographic data were unavailable for this secondary
analysis.
Participants were followed up 8–10 times over 2 years,
and on each occasion, they were encouraged to reduce
smoking by using NRT or placebo and given behavioural
strategies to assist. In addition, investigators collected
data on CPD, 7-day point prevalence abstinence,
recorded an expired air carbon monoxide reading
(CO), and at baseline and some other follow-ups mea-
sured quality of life using the RAND-36. This scale is
also known as the SF-36; however, the RAND-36 uses
slightly different scoring algorithms.23 Mental health was
measured by the emotional well-being subscale. On this
subscale, scores range from 0 to 100 and scores of ≤38
indicate a probable mental health problem.23 In the
general population, the subscale mean and SD are 70.4
(22.0). A minimally important difference on this sub-
scale has been deﬁned as a standardised effect size
ranging between 0.09 and 0.28.24
Exposure
We classiﬁed a person as having achieved prolonged ces-
sation if they were abstinent at both 6 and 12 months
and were biologically veriﬁed to be so on both occasions
by having a CO reading of <10 ppm. We classiﬁed a
person as smoking continuously if they reported
smoking at both times and had a CO reading of
≥10 ppm. We excluded from the analysis anyone not
meeting either deﬁnition.
Outcome
The primary outcome was change in mental health from
baseline (when all participants were smoking) to
12-month follow-up (after at least 6 months of continu-
ous abstinence or continued smoking).
Analysis
If participants were missing any relevant data, they were
excluded from the analysis. In the ﬁrst model, we used a
linear regression to examine the association between
cessation and change in mental health. Because of
regression to the mean when using within-person,
repeated measures data, participants’ mean change
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scores were not used to measure change in mental
health from baseline to follow-up; instead we used
follow-up mental health scores, with adjustment for base-
line mental health (see Vickers and Altman25 for
further explanation). We used a dummy variable repre-
senting cessation. We then adjusted for FTND score and
treatment allocation (active/placebo), age, sex and trial
ID. Second, we repeated this regression model using
propensity score-matched groups (described below). To
determine if the association was clinically important, we
calculated Cohen’s d and 95% CIs using a standard
formula,26–28 before and after matching.24 Finally, we
calculated Bayes factor to determine if the PSM analysis
lost power to detect an association or if the PSM analysis
indicated a true null result.29 The Bayes calculation
assumed a uniform distribution between zero, no associ-
ation, and the coefﬁcient for the unadjusted regression.
PSM procedure
PSM involved three steps towards building a logistic
regression model to derive predictors of quitting. (1)
Propensity scores were developed using covariates which
predicted smoking status: nicotine dependency
(FTND)21 and treatment allocation20 were forced into
the model; and a forward stepwise procedure was used
to determine whether baseline mental health, intention
to quit, intention to reduce, sex, age, smoking history,
SF-36, CPD, rated relief from smoking questionnaire,
were also associated with quitting at the p<0.10 level. (2)
This logistic regression model was combined with the
PSMATCH2 command in Stata V.13 to calculate propen-
sity scores representing the estimated probability of quit-
ting contingent on each participant’s baseline
characteristics.30 Quitters were matched to the continu-
ing smoker with the closest propensity score on a ratio
of 1:1 using a nearest neighbour greedy algorithm, with
no replacement, and matching was restricted to within
the common support region.31 32 (3) We performed
various checks to ensure the adequacy of the model. We
checked the balance of means and variances of
covariates after matching15 33 by examining the standar-
dised mean differences between smokers and quitters,
before and after matching; after matching bias should
be ≤5%34 to determine an adequate model. We calcu-
lated the achieved percentage of reduction in bias34 and
examined scatter plots comparing each covariate’s stan-
dardised per cent bias before and after matching. We
also examined the kernel density estimate of the prob-
ability distribution of propensity scores before and after
matching.
Sensitivity analyses
We developed three sensitivity analyses using different
PSM models. Our adjusted regression model was rerun
for each sensitivity analysis, and we compared the regres-
sion coefﬁcients between the sensitivity models. The
trials measured key baseline variables consistently, and
each trial also measured some variables in a different
manner compared with the other trials. Therefore, we:
(1) matched participants across trials including variables
measured consistently; (2) matched participants within
trials using all relevant variables. We repeated matching
across or within trials, with and without common
support restrictions. Table 1 summarises the PSM main
model and sensitivity analyses.
Assessment of risk of bias
Risk of bias was assessed using an adapted version of the
Newcastle-Ottawa Scale for risk assessment of observa-
tional studies.10 35
RESULTS
Unmatched participants
Sixty-eight participants were biologically validated as
continuous quitters and 589 as continuous smokers.
Three smokers and one quitter were excluded because
of missing baseline data on mental health. Twenty-six
smokers were missing outcome data. Smokers excluded
for missing data were psychologically healthy at base-
line22; mental health scores were M (SD)=74.0 (15.7),
Table 1 Summary of PSM main model and sensitivity analyses, and linear regressions conducted after matching
PSM method Linear regression model in PSM sample
Matching within/
across trials
Within/without common
support restriction Exposure Outcome Adjusted for
Within trials Within* Smoking
status
Mental health (SF-36)† at
12-month follow-up
Baseline mental health,
age, sex
Without Smoking
status
Mental health (SF-36)† at
12-month follow-up
Baseline mental health,
age, sex
Across trials Without Smoking
status
Mental health (SF-36)† at
12-month follow-up
Baseline mental health,
age, sex, trial ID
Within Smoking
status
Mental health (SF-36)† at
12-month follow-up
Baseline mental health,
age, sex, trial ID
*Main model.
†Emotional well-being subscale.
PSM, propensity score matching; SF-36, 36-item Short Form Survey.
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similar to included smokers. After exclusion for missing
data, 67 participants were biologically validated as quit
and 560 as smokers. Table 2 displays baseline character-
istics of unmatched smokers and quitters. There were
differences between groups’ FTND scores (p<0.001) and
the proportion who received active treatment (p=0.001).
The association between smoking cessation and change
in mental health in the whole sample
Mental health scores improved in both groups. The
mean change in the quit group was 4.9 (95% CI 1.1 to
8.7) compared with 1.0 (95% CI −0.4 to 2.4) in continu-
ing smokers (ﬁgure 1). The difference between groups’
follow-up mental health scores adjusted only for baseline
mental health was 5.48 (95% CI 1.62 to 9.35, p<0.001).
After further adjustment for FTND, treatment status,
age, sex and trial ID, the difference between groups
remained signiﬁcant (B=4.53, 95% CI 0.56 to 8.49,
p=0.025; table 3).
PSM main model
Table 4 presents ORs and 95% CIs for baseline covari-
ates which predicted smoking status at p<0.10, after
forced entry of FTND and treatment allocation.
Covariates which predicted smoking status were different
within trials and included: FTND scores, active treat-
ment, age started smoking, report of calming effects
from smoking, report of unpleasant symptoms from
smoking, length of time to last cessation attempt, experi-
ence from last cigarette, longest period without
smoking, SF-36 mental health (1 trial).
Main model adequacy checks
In all cases, variables which were signiﬁcantly imbal-
anced between groups before matching were no longer
signiﬁcantly imbalanced after matching. There were no
cases where variables became signiﬁcantly imbalanced
after matching.
Difference in bias between groups after matching was
examined to determine which variables were adequately
matched. For trial 1, 3/6 variables were adequately
matched; trial 4, 0/2; and trial 5, 3/6 variables were
adequately matched. In trials 2 and 3, all variables were
adequately matched. In sum, matching led to a ≥90%
reduction in bias for 13/20 variables (see online
supplementary table S2).
As shown in ﬁgure 2, there was a common support
area to perform PSM, and participants were predomin-
ately matched within the common region.
Participants after PSM
The main PSM model included 67 biologically validated
continuous quitters who were matched to 67 smokers
with similar propensity scores. Sixteen participants, eight
per matched sample, were lost as they did not fall within
the common support; those excluded did not differ
from the included sample at baseline. Excluded partici-
pants’ baseline mental health scores were: M (SD), 77.0
(14.6) for smokers and 73.5 (16.4) for quitters. FTND
scores of excluded smokers were 4.0 (2.4) and 3.4 (1.9)
for quitters. Six excluded smokers and seven excluded
quitters received active NRT treatment. Before PSM,
there were signiﬁcant differences between the groups’
nicotine dependency scores (FTND) and the number of
people receiving active treatment (table 2). After match-
ing, the sample became balanced on all baseline
characteristics, as displayed in table 5.
The association between smoking cessation and mental
health in the PSM sample
After matching, quitters showed an improvement in
mental health 4.5 (95% CI 0.4 to 8.7) and smokers dis-
played a slight worsening in mental health −0.2 (95% CI
−4.8 to 4.3; ﬁgure 3). The difference between groups
after adjustment for baseline values and covariates was
3.37 (−2.15 to 8.90), p=0.229 (table 6).
Table 2 Baseline characteristics in the unmatched sample
Smokers (n=560) Quitters (n=67) Test of significance p Value
Age, M (SD) 45.6 (10.6) 46.2 (10.2) T=−0.52 0.607
Sex, % male (N) 48 (258) 52 (35) χ2=0.42 0.515
FTND, M (SD) 6.2 (1.9) 5.3 (2.5) T=3.42 <0.001
SF-36 mental health, M (SD) 71.2 (17.5) 74.8 (13.6) T=−1.64 0.101
Treatment status, % received active (N) 50 (280) 72 (48) χ2=11.42 <0.001
FTND, Fagerström Test of Nicotine Dependency; SF-36, 36-item Short Form Survey.
Figure 1 Unmatched groups’ mental health scores M (SE) at
baseline and follow-up.
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Minimal clinically important difference
Cohen’s d for the standardised effect size was d=0.42
(95% CI 0.16 to 0.67) for the unmatched sample, which
suggests a clinically important association. After match-
ing, the effect became imprecise 0.14 (95% CI −0.22 to
0.50); however, the minimal clinically important differ-
ence (MCID) was still included in the CI.
Bayes factor
Bayes factor was 1.41 which indicated that the PSM data
were insensitive, and therefore the PSM results cannot
be used to infer that the effect from the regression ana-
lysis completely attenuated after matching participants,
but it also does not provide strong evidence that the
association is still present after matching.29
PSM sensitivity models
When matching was repeated across trials (see online
supplementary table S3), variables that contributed to
propensity scores were similar when matching was con-
ducted within trials. When the models were run without
restricting to the area of common support, smokers and
quitters still presented balanced baseline mental health
scores (see online supplementary table S4). At follow-up,
smokers’ mean scores showed little change, and in all
analyses, quitters showed a moderate improvement in
mental health scores. The coefﬁcients for the difference
in mental health at follow-up with baseline adjustment,
between quitters and continuing smokers, ranged from:
regression coefﬁcient B=3.96 (95% CI −1.00 to 8.93) to
3.55 (−1.29 to 8.40; see online supplementary table S4).
Risk of bias
Risk of bias to the association was assessed using an
adapted version of the Newcastle-Ottawa Scale.10 This
study scored 4/5 indicating a low risk of bias (see online
supplementary table S5).
DISCUSSION
In this study, regression modelling showed evidence that
cessation was associated with improved mental health
compared with continuing to smoke, and the direction
of the association was not altered by adjustment for con-
founding. PSM offers potential to control membership
Table 3 Adjusted linear regression model in whole sample
Predictors
Regression
coefficient (B)
and 95% CI
p
Value
Smoking status 4.53 (0.56 to 8.49) 0.025
Baseline mental health 0.54 (0.46 to 0.61) <0.001
NRT (active=1) 0.47 (−1.93 to 2.86) 0.703
FTND score −0.57 (−1.19 to 0.06) 0.062
Sex (female=1) −2.69 (−5.10 to −0.29) 0.028
Age 0.04 (−0.08 to 0.15) 0.54
Trial ID (reference=1)
2 6.04 (2.39 to 9.69) 0.001
3 2.84 (−1.04 to 6.72) 0.151
4 1.68 (−1.69 to 5.04) 0.329
5 2.69 (−0.99 to 6.38) 0.152
FTND, Fagerström Test of Nicotine Dependency; NRT, nicotine
replacement therapy.
Table 4 Main PSM model: OR and 95% CI for baseline predictors of smoking status at follow-up
Trial ID Covariate OR (95% CI) (quit=1) p Value
1 FTND 0.52 (0.36 to 0.74) <0.001***
Active treatment (active=1) 0.41 (0.09 to 1.86) 0.250
Age started smoking 1.38 (1.18 to 1.62) <0.001***
Calming effect from smoking 2.15 (1.15 to 4.00) 0.016*
Number of unpleasant symptoms from smoking 2.17 (1.12 to 4.20) 0.021*
Time to last cessation attempt 3.74 (0.85 to 16.38) 0.080*
2 FTND 0.87 (0.59 to 1.27) 0.460
Active treatment (active=1) 11.65 (1.38 to 98.17) 0.024*
Pleasant experience from last cigarette 2.36 (1.00 to 5.41) 0.043*
3 FTND 0.98 (0.74 to 1.30) 0.907
Active treatment (active=1) 3.06 (0.77 to 12.14) 0.112
Longest period without smoking 1.87 (1.07 to 3.26) 0.028*
4 FTND 0.80 (0.55 to 1.16) 0.241
Active treatment (active=1) 2.91 (0.50 to 16.79) 0.232
5 FTND 0.85 (0.62 to 1.16) 0.316
Active treatment (active=1) 6.07 (1.75 to 21.05) 0.004**
Pleasant experience from last cigarette 0.43 (0.24 to 0.77) 0.005**
SF-36 mental health 1.05 (1.01 to 1.09) 0.021*
Age started smoking 0.77 (0.59 to 1.00) 0.046*
Age 1.07 (1.00 to 1.15) 0.043*
See online supplementary table S1 for variable characteristics.
*p<0.1, **p<0.01, ***p<0.001.
FTND, Fagerström Test of Nicotine Dependency; PSM, propensity score matching; SF-36, 36-item Short Form Survey.
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bias as well as confounding. Using this technique, we
achieved a good match between smokers that continued
smoking and those that stopped. Doing so, the regres-
sion coefﬁcient for the difference between smokers and
quitters differed only slightly from that achieved by
regression methods alone, but it was no longer signiﬁ-
cant. However, Bayes factor indicated that the PSM data
were insensitive and cannot be used to infer that the
effect from the regression was completely attenuated by
matching participants.29
Strengths and limitations
There were some important strengths of the study. Data
were collected in a rigorous manner with clear biologic-
ally veriﬁed criteria to differentiate continuing smokers
from quitters. We included all the key covariates that a
systematic review reported were associated with achieving
abstinence.36 Mental health was assessed using a psycho-
metrically sound tool,22 24 and participants in the trials
were not aware of our hypothesis, so there were no
demand characteristics that might have biased the
results. The Newcastle-Ottawa Score suggested that the
results were unlikely to be subject to bias. After PSM, we
achieved a good balance of covariates, and extensive sen-
sitivity analysis showed no evidence that the results were
sensitive to the methodological decisions we made.
There were some limitations. The regression analysis was
based on a large sample and gave sufﬁcient precision to
give a statistically signiﬁcant result. The analysis using PSM
necessarily limited the sample size, and the estimate was no
longer as precise and was not signiﬁcant. Importantly
though, the direction of the regression coefﬁcient did not
change and the size did not change greatly after matching.
Although PSM theoretically balances covariates between
groups, one cannot be certain, especially with regard to
unmeasured variables.12 13 The overlap of propensity
scores in unmatched groups shows there was a small to
medium region to conduct matching, and a small
common support region may restrict the estimation of a
causal effect by changing the observed population.37
However, sensitivity analyses showed the association was
similar regardless of matching within or outside the
common region. Furthermore, those excluded during
support restrictions had similar baseline characteristics to
the entire cohort suggesting that restriction to the
common area did not introduce bias. Multiple sensitivity
analyses showed no evidence that change in the analysis
method altered the effect estimate. The trials included in
this analysis measured all key variables consistently;
however, some variables were not measured consistently
across trials. To investigate whether this inconsistency inﬂu-
enced the results, we conducted sensitivity analyses which
indicated that this was unlikely. However, in an ideal
Figure 2 Overlay of Kernel density distributions of quitters’
and smokers’ propensity scores before and after propensity
score matching.
Table 5 Baseline characteristics after PSM
Smokers (n=59) Quitters (n=59)
Test of significance p ValueM (SD) M (SD)
Age 48.34 (10.39) 45.76 (8.97) t=1.44 0.152
Sex (% male) 46 53 χ2=0.54 0.461
FTND 5.58 (2.13) 5.56 (2.43) t=0.04 0.968
SF-36 mental health 77.49 (15.07) 74.98 (13.28) t=0.95 0.340
Treatment status (% received active) 29 31 χ2=0.04 0.840
FTND, Fagerström Test of Nicotine Dependency; PSM, propensity score matching; SF-36, 36-item Short Form Survey.
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analysis, all variables would have been measured consist-
ently. To protect patient conﬁdentiality, this analysis did not
include certain demographic characteristics, such as ethni-
city, social class and education, as covariates. These demo-
graphics are possible predictors of change in smoking
status; however, a recent systematic review did not ﬁnd con-
sistent evidence to support this.36 It is also possible that
these demographics may predict the likelihood of experi-
encing change in mental health. However, for example, if
ethnicity predicts change in mental health, this is likely to
be true in both quitters and smokers. Therefore, although
these characteristics may appear important, confounding
occurs only if the strength or direction of association
changes between baseline and follow-up and that change
differs by group. For these reasons, it is unlikely that
excluding these characteristics from the analysis inﬂuenced
the association. However, interactions may still be possible.
Interpretation
The effect sizes reported here are similar to a recently
reported systematic review10 which examined studies
similar to this in that mental health was measured
before and after cessation in quitters and at correspond-
ing time points in continuing smokers. None of the
studies in the review had used PSM and few of them had
used regression modelling to adjust for potential con-
founders. This study therefore adds to previous work in
this ﬁeld by allaying concerns that the apparent beneﬁts
of cessation on mental health are spurious and arise
instead from differences between those who stop and
those who do not stop smoking.
In our systematic review,10 we proposed that the
improvement in mental health occurred because after
cessation, regular smokers no longer experienced
periods of withdrawal-induced negative affect between
cigarettes. This would imply that smoking may be the
cause symptoms of depression and anxiety. However, a
Mendelian randomisation study found only scant evi-
dence to suggest any association between the genetic
instrument and anxiety and depression symptoms38; this
might suggest that the improvement in mental health
that appears to arise after cessation is not due to relief
of the smoking-induced withdrawal symptoms.
Implications
The effect size reported here is similar in size to that
reported in systematic reviews of the effects of antide-
pressants for anxiety and depression39 40 and is larger
than that deemed clinically important on the emotional
well-being subscale of the RAND-36. This study adds to
the growing evidence from observational research that
cessation interventions in the general population and in
those with mental health problems10 at least do no psy-
chological harm and may indeed be therapeutic. This
evidence is supported by trials of cessation interventions
in people with mental health problems, which show no
evidence of harm and small suggestions of beneﬁt to
mental health from cessation interventions.41 42
CONCLUSION
In summary, this study used PSM to try to control mem-
bership bias and confounding, and found a similar
effect size to that observed using regression modelling
alone. This suggests that membership bias or confound-
ing partly but not completely explains the apparent
beneﬁt of cessation on mental health and strengthens
the case that cessation itself is the cause.
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Figure 3 Matched groups’ mental health scores M (SE) at
baseline and follow-up.
Table 6 Adjusted linear regression model in PSM sample
Predictors
Regression coefficient (B)
and 95% CI
p
Value
Smoking status 3.37 (−2.15 to 8.90) 0.229
Baseline mental
health
0.41 (0.21 to 0.61) <0.001
Sex (female=1) −2.75 (−8.23 to 2.74) 0.324
Age 0.11 (−0.17 to 0.40) 0.435
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